Loading...
XNAS
APYX
Market cap99mUSD
Oct 08, Last price  
2.36USD
1D
-7.45%
1Q
-46.12%
Jan 2017
-34.26%
Name

Apyx Medical Corp

Chart & performance

D1W1MN
XNAS:APYX chart
P/E
—
P/S
1.88
EPS
—
Div yield, %
—
Shrs. gr., 5y
4.27%
Rev. gr., 5y
13.78%
Revenues
53m
+9.86%
26,676,18228,779,15728,096,51026,953,44724,230,00025,411,00027,671,00023,660,00027,681,00029,520,00036,627,00038,883,00016,686,00028,235,00027,711,00048,517,00044,510,00052,349,00048,102,00052,844,000
Net income
-11m
L-52.22%
2,683,2062,400,5911,831,788595,522-1,535,000109,000617,000-4,339,000-17,282,000-5,370,000-3,950,000-5,062,00064,009,000-19,706,000-11,896,000-15,172,000-23,184,000-18,713,000-23,463,000-11,211,000
CFO
-8m
L-55.67%
2,986,2182,041,344742,829-98,332-566,0001,897,000165,000-2,536,000-417,000-5,786,000-2,837,000-3,704,000-21,011,000-18,475,000-16,066,000-10,449,000-20,280,000-5,249,000-18,047,000-8,001,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Key people

Andrew Makrides
Chairman of the Board · since 2017
Charles D. Goodwin
Chief Executive Officer, Director · since 2017
John C. Andres
Independent Vice Chairman of the Board · since 2018
Todd Hornsby
Executive Vice President · since 2019
Moshe Citronowicz
Senior Vice President · since 2011
Tara Harris Semb
Chief Financial Officer, Treasurer, Secretary · since 2019
Lead Independent Director · since 2011
Chief Executive Officer, Director · since 2013
Michael E. Geraghty
Independent Director · since 2011
IPO date
Jul 22, 1983
Employees
276
Domiciled in
US
Incorporated in
US
Legal address
c/o UNITED CORPORATE SERVICES, INC., 874 WALKER RD STE C
Dover, DE 19904
US
Headquarters
5115 Ulmerton Road
Clearwater, FL 33760-4004
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT